|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||1.42 - 1.52|
|52 Week Range||0.60 - 2.86|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 6, 2018 - Aug 10, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.80|
On Tuesday, July 17, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Six out of nine sectors ended Tuesday's trading session in bullish territories. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Healthcare equities this morning: Brookdale Senior Living Inc. (NYSE: BKD), Envision Healthcare Corp. (NYSE: EVHC), Genesis Healthcare Inc. (NYSE: GEN), and Acceleron Pharma Inc. (NASDAQ: XLRN).
DNA testing at home in Japan is starting to gain traction as more people age and seek answers about their risks for diseases. The market for consumer genetic tests is poised to reach 6.6 billion yen ($58 million) in sales by 2022, up from 4.3 billion yen last year, according to Fuji Chimera Research Institute. The sector is dominated by two local companies, Genesis Healthcare Co. and Genequest Inc. For 5,000 yen to 30,000 yen, customers can send off a cheek swab to find out their propensities for alcohol intolerance and allergies, to risks of diabetes and strokes.
Sabra Health Care (SBRA) to use proceeds from sale of nine Genesis Healthcare facilities, and another project leased to Signature Healthcare to reduce balance under its revolving credit facility.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Genesis HealthCare, one of the largest post-acute care providers in the United States, today announced that eight of its centers have been recognized as a 2018 recipients of the Bronze – Commitment to Quality Award for their commitment to improving the lives of residents through quality care. The distinction is the first of three progressive award levels through the National Quality Award Program, presented by the American Health Care Association and National Center for Assisted Living (AHCA/NCAL), the leading association for long term and post-acute care. The program honors association members across the country that have demonstrated their dedication to improving quality of care for seniors and persons with disabilities.
How far off is Genesis Healthcare Inc (NYSE:GEN) from its intrinsic value? Using the most recent financial data, I am going to take a look at whether the stock isRead More...
NEW YORK, June 14, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Charter ...
LONDON, UK / ACCESSWIRE / June 13, 2018 / If you want a free Stock Review on EVHC sign up now at www.wallstequities.com/registration. Under evaluation are Brookdale Senior Living Inc. (NYSE: BKD), Envision Healthcare Corp. (NYSE: EVHC), Genesis Healthcare Inc. (NYSE: GEN), and Kindred Healthcare Inc. (NYSE: KND). Shares in Brentwood, Tennessee headquartered Brookdale Senior Living Inc. rose slightly by 0.88%, ending Tuesday's trading session at $9.13.
The region is now home to 14 members of the annual list of the 500 highest grossing U.S. companies, with another 13 being ranked between No. 501 and No. 1000.
Thomas DeRosa is making a $4 billion bet that he can build a national, low-cost healthcare network for America's aging population that will succeed where so many other models have struggled. DeRosa's strategy starts with buying out the property of the huge bankrupt nursing home chain HCR ManorCare, and teaming up with a non-profit hospital operator, ProMedica, to create a 30-state healthcare system.
Stock Research Monitor: BKD, GEN, and KND LONDON, UK / ACCESSWIRE / May 14, 2018 / If you want a free Stock Review on EVHC sign up now at www.wallstequities.com/registration . Research reports have been ...
On a per-share basis, the Kennett Square, Pennsylvania-based company said it had a loss of 70 cents. Losses, adjusted for asset impairment costs and to extinguish debt, were 39 cents per share. The operator ...
KENNETT SQUARE, Pa., May 10, 2018-- Genesis Healthcare, Inc., one of the largest post-acute care providers in the United States, today announced operating results for the first quarter ended March 31, ...
“During the first quarter of 2018, we saw regulatory progress with DARZALEX in multiple myeloma, continued to progress our innovative pipeline, and experienced good progress in a number of antibody programs run by our collaboration partners. Revenue was DKK 681 million in the first quarter of 2018 compared to DKK 251 million in the first quarter of 2017. The increase of DKK 430 million, or 171%, was mainly driven by the payment from Novartis of USD 50 million and higher DARZALEX royalties.
Genesis HealthCare (GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it expects to release its first quarter 2018 results before the market opens on Thursday, May 10, 2018. To participate in the call, interested parties may dial (855) 849-2198 or listen to a live webcast and replay of the call on the Company’s website at http://www.genesishcc.com/investor-relations. Genesis HealthCare (GEN) is a holding company with subsidiaries that, on a combined basis, comprise one of the nation's largest post-acute care providers with more than 450 skilled nursing facilities and assisted/senior living communities in 30 states nationwide.
I am going to take a deep dive into Genomed Spólka Akcyjna’s (WSE:GEN) most recent ownership structure, not a frequent subject of discussion among individual investors. Ownership structure has beenRead More...
Genesis is selling a majority stake in its GRS-HS subsidiary. The company provides rehabilitation therapy services in 12 facilities in Hong Kong, Guangzhou, and various cities in Zhejiang, Shanghai, Beijing and Qinhuangdao.
Genesis HealthCare (Genesis, or the Company) (GEN), one of the largest post-acute care providers in the United States, today announced that it has signed a definitive agreement to sell 51% of its subsidiary in China, referred to as GRS-HS, to Riswein Health Industry Investment Co., Ltd (Riswein) for $30 million. The transaction is expected to close in the first quarter of 2019 and is subject to regulatory and licensing approvals, and other customary conditions. In the coming weeks, GRS-HS will seek approval for a new, wholly owned foreign entity (WOFE) in China. GRS-HS expects the process to take about 9 months to complete. Upon formation of the WOFE, Riswein will invest $30 million for a 51% stake in the WOFE and GRS-HS will own the remaining 49%. In the interim, Riswein will lend GRS-HS $5 million, which will fund operating expenses during the WOFE approval process.
The Chester County company getting out of the inpatient long-term care business in Texas in a move to further reduce its heavy debt lead.
For Genomed Spólka Akcyjna’s (WSE:GEN) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. The beta measuresRead More...